DSD-T211

Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T211

DSD-T211 · Congenital adrenal hyperplasia (CAH) · 2021 · Automated translation

Genes CYP17A1 · Karyotype 46,XY

46,XY isolated 17,20-lyase deficiency due to compound heterozygous CYB5A variants (ambiguous genitalia, insufficient masculinization at puberty).

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Age

Neonatal onset, followed up to adulthood

Sex

Male (46,XY, ambiguous genitalia at birth)

Karyotype

46,XY

Genetics

CYP17A1

Diagnosis

46,XY isolated 17,20-lyase deficiency due to compound heterozygous CYB5A variants (ambiguous genitalia, insufficient masculinization at puberty).

Follow-up

Long-term follow-up showed stable testicular microlithiasis and persistent primary hypogonadism; transferred to adult endocrinology to continue testosterone replacement.

General phenotype

Male phenotype; puberty started spontaneously but progression stalled, requiring testosterone replacement; at end of treatment Tanner P5/G5, testes 15–20 mL.

Imaging

Testicular ultrasound from age 4 showed testicular microlithiasis, stable from childhood through puberty.

Laboratory findings

Neonatal hCG-stimulated testosterone <0.3→0.6 nmol/L, androstenedione <0.8→0.8 nmol/L; cortisol 150 nmol/L, 17-OHP 24 nmol/L, LH 1.2 IU/L, FSH 1.8 IU/L; methemoglobin (MetHb) 0.104 mmol/mmol Hb (<0.01).

Management

Intramuscular testosterone for 3 months during infancy; hypospadias repair and correction of penoscrotal transposition; long-term testosterone replacement from age 14; reduction mammoplasty at age 12.

Pathology

Testicular biopsy showed only microliths (calcifications), no evidence of malignancy.

Evidence level

See source

Clinical history

See source

Family history

See source

External genital examination

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T211 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T211?version=v1.4.0